Mira Pharmaceuticals, Inc. SEC filings MIRA
Mira Pharmaceuticals, Inc. has 198 filings in SEC EDGAR's recent list, going back to Jun 29, 2022. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure).
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jul 28, 2026 | Jul 28, 2026 |
| DEFM14A | Filing | Aug 8, 2025 | — |
| DEFA14A | Additional proxy material | Aug 8, 2025 | — |
| PREM14A | Filing | Jun 17, 2025 | Jun 17, 2025 |
| DEFA14A | Additional proxy material | Jul 26, 2024 | — |
| DEF 14A | Proxy statement | Jul 26, 2024 | Jul 26, 2024 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRA (Nasdaq)
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1904286
- Former names
- Mira1a Therapeutics, Inc. (until May 2, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.